Mode of action and effectiveness of the monoclonal anti-CD20-antibody Obinutuzumab in non-Hodgkin's Lymphoma patients compared to Rituximab

Authors
Publication date
14 January 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver

    redirect
    oaioai:docserv.uni-duesseldorf.de...
    Last time updated on 16/01/2021